{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:24:05Z","timestamp":1768451045373,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2012\/50641-0"],"award-info":[{"award-number":["2012\/50641-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2016\/02012-4"],"award-info":[{"award-number":["2016\/02012-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2017\/26872-5"],"award-info":[{"award-number":["2017\/26872-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","award":["2015\/22944-6"],"award-info":[{"award-number":["2015\/22944-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["308144\/2014-7"],"award-info":[{"award-number":["308144\/2014-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejphar.2018.11.008","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T16:15:39Z","timestamp":1541780139000},"page":"298-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Involvement of the annexin A1-Fpr anti-inflammatory system in the ocular allergy"],"prefix":"10.1016","volume":"842","author":[{"given":"Mariana Prado","family":"Marmorato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Dantas","family":"Gimenes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans Eberth Costa","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia Maria","family":"Oliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane Damas","family":"Gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.11.008_bib1","first-page":"1003","article-title":"Galectin-3: role in ocular allergy and potential as a predictive biomarker. B","volume":"102","author":"Andrade","year":"2018","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib2","first-page":"3208","article-title":"Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist","volume":"17","author":"Baiula","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejphar.2018.11.008_bib3","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1124\/jpet.104.080473","article-title":"A novel effect for annexin 1-derived peptide ac2-26: reduction of allergic inflammation in the rat","volume":"313","author":"Bandeira-Melo","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.11.008_bib4","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.4049\/jimmunol.0903022","article-title":"Cutting edge: a critical role for the G protein-coupled receptor mFPR2 in airway inflammation and immune responses","volume":"184","author":"Chen","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.clim.2008.11.005","article-title":"Staphylococcus aureus accelerates an experimental allergic conjunctivitis by Toll-like receptor 2-dependent manner","volume":"131","author":"Chung","year":"2009","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ddmod.2011.06.004","article-title":"Mast cell proteases and inflammation","volume":"8","author":"Dai","year":"2011","journal-title":"Drug Discov. Today Dis. Models"},{"key":"10.1016\/j.ejphar.2018.11.008_bib7","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0002-9440(10)62471-6","article-title":"Critical protective role for annexin 1 gene expression in the endotoxemic murine microcirculation","volume":"166","author":"Damazo","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib8","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.4049\/jimmunol.0803128","article-title":"Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils","volume":"182","author":"Devosse","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib9","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.4049\/jimmunol.172.11.7053","article-title":"Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model","volume":"172","author":"Duan","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1476-5381.1988.tb11614.x","article-title":"Lipocortin and the mechanism of action of the glucocorticoids","volume":"94","author":"Flower","year":"1988","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib11","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1182\/blood-2002-11-3411","article-title":"Leukocyte antiadhesive actions of annexin 1: alxr-and FPR-related anti-inflammatory mechanisms","volume":"101","author":"Gavins","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.11.008_bib12","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1096\/fj.06-7842com","article-title":"Activation of the annexin 1 counter-regulatory circuit affords protection in the mouse brain microcirculation","volume":"21","author":"Gavins","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2018.11.008_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2015.03.013","article-title":"Beneficial effect of annexin A1 in a model of experimental allergic conjunctivitis","volume":"134","author":"Gimenes","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2018.11.008_bib14","doi-asserted-by":"crossref","first-page":"5689","DOI":"10.4049\/jimmunol.1202030","article-title":"Anti-inflammatory mechanisms of the annexin A1 protein and its mimetic peptide Ac2-26 in models of ocular inflammation in vivo and in vitro","volume":"190","author":"Girol","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib15","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1096\/fj.02-0239fje","article-title":"Aberrant inflammation and resistance to glucocorticoids in annexin 1\u2212\/\u2212 mouse","volume":"17","author":"Hannon","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2018.11.008_bib16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.injury.2015.03.028","article-title":"N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1\/2 and P38 MAP kinase signalling pathways","volume":"46","author":"Hazeldine","year":"2015","journal-title":"Injury"},{"key":"10.1016\/j.ejphar.2018.11.008_bib17","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/bph.13847","article-title":"Mast cells mediate early neutrophil recruitment and exhibit anti\u2010inflammatory properties via the formyl peptide receptor 2\/lipoxin A4 receptor","volume":"174","author":"Hughes","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib18","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.bbrc.2011.12.084","article-title":"Anti-inflammatory effects of Tat-Annexin protein on ovalbumin-induced airway inflammation in a mouse model of asthma","volume":"417","author":"Lee","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2018.11.008_bib19","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1167\/iovs.14-15100","article-title":"Immunomodulatory effects of galectin-1 on an IgE-mediated allergic conjunctivitis model","volume":"56","author":"Mello","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2018.11.008_bib20","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0002-9440(10)64002-3","article-title":"Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression","volume":"158","author":"Oliani","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib21","doi-asserted-by":"crossref","first-page":"e0175786","DOI":"10.1371\/journal.pone.0175786","article-title":"Characterizing the anti-inflammatory and tissue protective actions of a novel Annexin A1 peptide","volume":"12","author":"Perretti","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.11.008_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mi.2013.37","article-title":"Pleurocidin, a novel antimicrobial peptide, induces human mast cell activation through the FPRL1 receptor","volume":"7","author":"Pundir","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib23","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1242\/jcs.01245","article-title":"Annexins\u2013unique membrane binding proteins with diverse functions","volume":"117","author":"Rescher","year":"2004","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejphar.2018.11.008_bib24","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1167\/iovs.10-5598","article-title":"In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease","volume":"52","author":"Shafiee","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2018.11.008_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10384-004-0187-3","article-title":"Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB\/c mice","volume":"49","author":"Shoji","year":"2005","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib26","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1096\/fj.14-263160","article-title":"Targeting formyl peptide receptor 2 reduces leukocyte-endothelial interactions in a murine model of stroke","volume":"29","author":"Smith","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2018.11.008_bib27","doi-asserted-by":"crossref","first-page":"e0130803","DOI":"10.1371\/journal.pone.0130803","article-title":"Ac2-26 mimetic peptide of annexin A1 inhibits local and systemic inflammatory processes induced by Bothrops moojeni venom and the Lys-49 phospholipase A2 in a rat model","volume":"10","author":"Stuqui","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.11.008_bib28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1189\/jlb.0908514","article-title":"Interplay between signaling via the formyl peptide receptor (FPR) and chemokine receptor 3 (CCR3) in human eosinophils","volume":"86","author":"Svensson","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000320228","article-title":"Annexin 1-derived peptide Ac2-26 inhibits eosinophil recruitment in vivo via decreasing prostaglandin D2","volume":"154","author":"Wang","year":"2011","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib30","doi-asserted-by":"crossref","first-page":"7050","DOI":"10.4049\/jimmunol.177.10.7050","article-title":"The immunosuppressant cyclosporin A antagonizes human formyl peptide receptor through inhibition of cognate ligand binding","volume":"177","author":"Yan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.11.008_bib31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1734-1140(10)70307-8","article-title":"Anti-allergic drugs and the Annexin-A1 system","volume":"62","author":"Yazid","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2018.11.008_bib32","doi-asserted-by":"crossref","first-page":"e58963","DOI":"10.1371\/journal.pone.0058963","article-title":"Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1","volume":"8","author":"Yazid","year":"2013","journal-title":"PLoS One"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918306575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918306575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T04:55:11Z","timestamp":1545022511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918306575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":32,"alternative-id":["S0014299918306575"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.11.008","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of the annexin A1-Fpr anti-inflammatory system in the ocular allergy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}